Trump’s HHS nominee reaped big earnings from drug industry tenure
As a top pharma industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth as much as $20.6 million.
As a top pharma industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth as much as $20.6 million.
Experts say wider availability of no-premium plans is the unintended consequence of Trump administration actions to undermine the Affordable Care Act.
Mainstreet Health Investments Inc., a company founded by Carmel-based Mainstreet Property Group, has reached a deal to acquire Care Investment Trust LLC, which owns 42 senior housing and care properties.
U.S. health authorities have cleared a brain-stimulating device made by an Indiana-based company for patients suffering from debilitating withdrawal symptoms caused by addiction to heroin and other opioids.
The single-story, 35,000-square-foot building is on 17 acres on the southwest corner of 61st Street and Lake Park Avenue, south of the St. Mary Medical Center.
The Indianapolis-based health system said Nov. 3 that it recovered the bag of paperwork within hours and began an internal investigation.
The clinic, at 3737 Waldemere Ave., will offer treatments for minor injuries and illnesses that do not require a visit to the emergency room.
Health care providers’ frustration is running high, and even advocates say the movement has fallen short.
The plan released Tuesday night by Senate Republicans mixes two red-hot debates by adding a repeal of the Obamacare law’s individual mandate to their tax legislation.
Sign-ups for Affordable Care Act health plans are running more than 45 percent ahead of last year's pace as people rush to meet a shorter deadline.
If confirmed by the Senate, former Eli Lilly and Co. exec Alex Azar will oversee a $1 trillion department responsible for major health insurance programs, medical research, food and drug safety, and public health.
Anthem said it has seen a drop in unnecessary ER visits in Kentucky since it started its review there and has rejected only around 1 percent of all claims as avoidable. The policy will expand to Indiana next year.
Alex Azar, who ran U.S. operations for Eli Lilly before leaving in January, would be the administration’s point person on running—or dismantling—Obamacare.
The Association of Indiana Prosecuting Attorneys argues any type of marijuana legalization would come with grave consequences.
Former UnitedHealth Group executive Gail Boudreaux, 57, is succeeding Joseph Swedish, 66, who will serve as executive chairman until mid-2018.
Gail Boudreaux’s appointment as CEO of Anthem Inc., announced on Monday, makes her the highest-ranking female executive in the health insurance industry.
The rate of deaths increased slightly in every quarter of 2016, indicating an accelerating epidemic. That crisis has been driven by opioid abuse.
Lilly CEO David Ricks says the time is right “to consider a variety of options to maximize future value,” such as an initial public offering. But analysts say an IPO would make more sense if Elanco were performing better.
After the deal closes, the insurers are expected to collectively cover more than 620,000 people and generate annual revenue approaching $6 billion.
Two national advocacy groups filed a federal lawsuit in Indiana on Tuesday challenging a rule change by President Donald Trump's administration allowing more employers to opt out of no-cost birth control for workers.